Should we rethink the indications for implantable cardioverter-defibrillators in non-ischaemic dilated cardiomyopathy?

Eur J Heart Fail. 2018 Mar;20(3):417-419. doi: 10.1002/ejhf.948. Epub 2017 Sep 18.

Authors

Antonio Curcio¹, Salvatore De Rosa¹, Ciro Indolfi^{1

2}

Affiliations

¹ Division of Cardiology, Department of Medical and Surgical Sciences, University Magna Graecia, Catanzaro, Italy.
² Unità di Ricerca presso Terzi (URT), Consiglio Nazionale delle Ricerche (CNR), Istituto di Fisiologia Clinica (IFC), Catanzaro, Italy.

PMID: 28925037
DOI: 10.1002/ejhf.948

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Cardiomyopathy, Dilated*
Death, Sudden, Cardiac
Defibrillators, Implantable*
Heart Failure
Humans
Risk Factors